相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ticagrelor with or without Aspirin in High-Risk Patients after PCI
R. Mehran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Platelet responses to pharmacological and physiological interventions in middle-aged men with different habitual physical activity levels
M. H. Lundberg Slingsby et al.
ACTA PHYSIOLOGICA (2018)
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
P2Y12 receptor blockade synergizes strongly with nitric oxide and prostacyclin to inhibit platelet activation
Melissa V. Chan et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Soluble guanylyl cyclase-activated cyclic GMP-dependent protein kinase inhibits arterial smooth muscle cell migration independent of VASP-serine 239 phosphorylation
Andrew W. Holt et al.
CELLULAR SIGNALLING (2016)
The importance of endothelium-derived mediators to the efficacy of dual anti-platelet therapy
Timothy D. Warner et al.
EXPERT REVIEW OF HEMATOLOGY (2016)
Long-term ticagrelor monotherapy versus standard dual antiplatelet therapy followed by aspirin monotherapy in patients undergoing biolimus-eluting scent implantation: rationale and design of the GLOBAL LEADERS trial
Pascal Vranckx et al.
EUROINTERVENTION (2016)
Novel whole blood assay for phenotyping platelet reactivity in mice identifies ICAM-1 as a mediator of platelet-monocyte interaction
Paul C. J. Armstrong et al.
BLOOD (2015)
Extending the translational potential of targeting NO/cGMP-regulated pathways in the CVS
Andreas Papapetropoulos et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Selexipag for the Treatment of Pulmonary Arterial Hypertension
Olivier Sitbon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Ezra A. Amsterdam et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failure
Erland Erdmann et al.
EUROPEAN HEART JOURNAL (2013)
Blockade of the purinergic P2Y12 receptor greatly increases the platelet inhibitory actions of nitric oxide
Nicholas S. Kirkby et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Activation of Haem-Oxidized Soluble Guanylyl Cyclase with BAY 60-2770 in Human Platelets Lead to Overstimulation of the Cyclic GMP Signaling Pathway
Camila B. Mendes-Silverio et al.
PLOS ONE (2012)
Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapy
Timothy D. Warner et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions
Glenn N. Levine et al.
CIRCULATION (2011)
Antiplatelet effects of aspirin vary with level of P2Y12 receptor blockade supplied by either ticagrelor or prasugrel
N. S. Kirkby et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
In the presence of strong P2Y12 receptor blockade, aspirin provides little additional inhibition of platelet aggregation
P. C. J. Armstrong et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Dual antiplatelet therapy in cardiovascular disease: does aspirin increase clinical risk in the presence of potent P2Y12 receptor antagonists?
Timothy D. Warner et al.
HEART (2010)
Reduction of platelet thromboxane A(2) production ex vivo and in vivo by clopidogrel therapy
P. C. J. Armstrong et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
P2Y12 antagonism -: Promises and challenges
Alan D. Michelson
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Review - Recent developments in nitric oxide donor drugs
M. R. Miller et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
2-{4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}-N(methylsulfonyl)acetamide (NS-304), an orally available and long-acting prostacyclin receptor agonist prodrug
Keiichi Kuwano et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential
Oleg V. Evgenov et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention - A randomized controlled trial
SR Steinhubl et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
分享论文
